Possible New Standard for Treated Advanced CRC With KRAS Mutations

(MedPage Today) -- SAN DIEGO -- A third of patients with previously treated unresectable/metastatic KRASG12C-mutated colorectal cancer (CRC) responded to a combination of targeted drugs, a preliminary prospective study showed. The results showed...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news